Mycronic AB (publ)
MICLF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $4 | $33 | $18 | $20 |
| - Cash | $0 | $2 | $3 | $3 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $3 | $32 | $15 | $17 |
| Revenue | $0 | $2 | $2 | $2 |
| % Growth | -91.2% | -3.5% | 4% | – |
| Gross Profit | $0 | $1 | $1 | $1 |
| % Margin | 46.3% | 53.4% | 61.2% | 48.8% |
| EBITDA | $0 | $1 | $1 | $1 |
| % Margin | 20.2% | 27.8% | 37.7% | 26% |
| Net Income | $0 | $0 | $1 | $0 |
| % Margin | 12.7% | 21.6% | 28.9% | 22.3% |
| EPS Diluted | 0.12 | 2.28 | 3.18 | 2.36 |
| % Growth | -94.7% | -28.3% | 34.7% | – |
| Operating Cash Flow | $0 | $0 | $0 | $1 |
| Capital Expenditures | -$0 | $0 | $0 | -$0 |
| Free Cash Flow | $0 | $0 | $0 | $1 |